Advertisement

Topics

DRUG DISCOVERT TODAY Company Profile

23:57 EDT 21st June 2018 | BioPortfolio

Nil

Contact

Email: ddt@drugdiscoverytoday.com.


News Articles [1474 Associated News Articles listed on BioPortfolio]

GWPH Faces FDA Panel Today, NVCR Reports STELLAR Data, 1st XLH Drug Cleared

Today's Daily Dose brings you news about Arcus' phase I trial data of AB928; FDA briefing documents related to GW Pharma's Epidiolex; STELLAR results of Novocure and FDA approval of Rigel's ITP drug a...

Drug Discovery Today: highlighted review. ‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries

This highlighted review from Drug Discovery Today by Dobson, Patel and Kell outlines how "metabolite-likeness" in an analogous manner to "drug-likeness" and "lead-likeness" can be used to improve the ...

Drug Discovery Today Citation Classic: The growing impact of click chemistry on drug discovery.

Welcome to the first article in Drug Discovery Today Citation Classics. I would say that it is very hard to predict what articles will make citation classic articles, but I suppose that having a Nobel...

Pain Therapeutics Resubmits New Drug Application for Remoxy ER, an Abuse-Deterrent, Extended-Release Drug Candidate for the Treatment of Chronic Pain

AUSTIN, Texas, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today the resubmission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) f...

FDA Accepts Remoxy NDA For Review

AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today that the U.S. Food and Drug Administration (FDA) has determined that a New Drug Application (NDA...

FDA Grants Orphan Drug Designation to SELLAS’ Investigational Multiple Myeloma Drug

NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group Inc. (Nasdaq:SLS) (“SELLAS”), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a br...

KMPH Gets FDA Nod, ADMP On Track, OBSV To Report Data Today

Today's Daily Dose brings you news about the progress related to commercial launch of Adamis Pharma's Symjepi; KemPharm's FDA approval of its pain drug; the regulatory catalyst for Mallinckrodt in Au...

Suspended for Drug Offenses, Now an Addiction Specialist

(MedPage Today) -- While on probation for prescription drug issues, doc gets new license in Florida

Clinical Trials [2433 Associated Clinical Trials listed on BioPortfolio]

TODAY! A Mobile App Study

The aim of this study is to conduct a small randomized controlled trial (RCT) for a 10-week mobile phone intervention using principles of Cognitive Behavior Therapy to target general and m...

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has sponsored a consortium of investigators to conduct a clinical tr...

Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens

The joint status (knees, ankles) of patients suffering from severe Hemophilia A (too little blood clotting factor VIII in blood) is evaluated in a single magnetic resonance imaging session...

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

The objective of the study is to evaluate the process of early re-endothelialization of the Coroflex® ISAR Drug-eluting stent compared with the Ultimaster® Drug-eluting stent

Basel Stent Kosten Effektivitäts Trial Drug Eluting Balloons vs. Drug Eluting Stents in Small Vessel Interventions

The investigators hypothesize that in a real-world population undergoing percutaneous coronary intervention (PCI) for de-novo stenoses in small native vessels with a diameter

Companies [1953 Associated Companies listed on BioPortfolio]

DRUG DISCOVERT TODAY

Nil

Lil' Drug Store Products, Inc.

Lil' Drug Store Convenience Division provides a wide variety of products and merchandising vehicles to convenience stores, club stores, and other classes of trade nationwide. Retailers can find everyt...

Verseon

Verseon is a technology-based pharmaceutical company that employs its proprietary computational drug discovery platform to develop novel therapeutics for today’s challenging ...

National Association of Chain Drug Stores

Founded in 1933 by six chain executives, the National Association of Chain Drug Stores worked to provide the chain drug industry with a unified voice necessary for growth and success. More than 70 yea...

Epic Therapeutics Incorporated

Epic Therapeutics, Inc. has developed a proprietary, protein-matrix drug delivery technology, ProMaxx®, that is produced entirely in water and is substantially more versatile and cost-effective at so...

More Information about "DRUG DISCOVERT TODAY" on BioPortfolio

We have published hundreds of DRUG DISCOVERT TODAY news stories on BioPortfolio along with dozens of DRUG DISCOVERT TODAY Clinical Trials and PubMed Articles about DRUG DISCOVERT TODAY for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DRUG DISCOVERT TODAY Companies in our database. You can also find out about relevant DRUG DISCOVERT TODAY Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record